Page 19 - Shimadzu Journal vol.7 Issue2

Topics

One award winner was Dr. Silvia Giordano (Mario Negri Institute
Milan), who in recent years has started a collaborative project with
Shimadzu at its Innovation Center in Germany, with the goal of rapid
and objective tumor identification. In her research, she uses Shimadzu’s
DPiMS-2020 (Direct Probe Ionization Mass Spectrometer), which was
developed to assist fast analysis of pathology specimens. It was created
together with Prof. Sen Takeda of the Faculty of Medicine at the University
of Yamanashi as part of a Japan Science and Technology Agency (JST)
program for the development of advanced measurement and analysis
systems. The implementation of this technology into the clinical field
is expected to reduce the surgical burden of cancer patients. Dr.
Giordano has coupled this technology with Artificial Intelligence to
obtain accurate and reproducible results.

Upon meeting at the 2017 Summit, they soon commenced a collaborative
research project. As Prof. Schug explained, this research aims to “to
develop methodology for intact protein quantitation using liquid
chromatography – triple quadrupole mass spectrometry.” In their
presentation, the two professors introduced their research and talked
about their collaboration in detail.
Prof. Schug also mentioned the Shimadzu technology that aided in
their research: “Shimadzu instrumentation is an essential part of our
analytical chemistry research. Shimadzu consistently offers new
instrumentation, which pushes the boundaries of what can be
measured. As one example, the variable collision gas pressure in the
LCMS-8050 and LCMS-8060 instruments is essential to being able to
fragment large biomolecules in a multiple reaction monitoring-type Another award winner, Dr. Adam Noah (Yale School of Medicine) has
experiment.”
focused his unique research on one of the most fundamental social
In addition, Prof. Schug underlined what they wish to achieve with interactions we make: eye contact. In this research, Dr. Noah made
their research: “We can contribute to society and the well-being of use of Shimadzu’s functional spectral neuroimaging technology.
humankind by helping clinicians better assess cancer diseases, as well Specifically, he seeks to understand the neurological basis of this
as to potentially help the pharmaceutical industry develop new interaction. To this end, he began a project investigating the role of
treatments.” direct eye contact in the modulation of activity in the temporal-parietal
junction as well as neural synchrony between interacting partners in
the face and socially-sensitive areas of the brain during direct eye gaze.

In addition, numerous other researchers introduced exciting
developments in their research that proposed new synergies
between analytical science and medical imaging technology.
Shimadzu hopes that these kinds of collaborations aimed at research
A poster session brimming with innovation breakthroughs in Advanced Healthcare were accelerated even further
at this year’s summit. The exchange of ideas between researchers
Following the initial round of speeches, the event moved on to the from differing backgrounds, and the innovation this has the potential
poster session, in which 57 guests and 15 Shimadzu employees to give rise to, is exactly in line with Shimadzu’s vision of Advanced
showcased their research. The open layout of the session allowed for Healthcare.
lively discussion between researchers from diverse fields. After voting
by all participants, a panel of judges determined 6 award winners, For more details, visit at:
who presented their research on the main stage the following day. https://www.shimadzu.com/an/gis/index.html

55